Substrate and inhibitor specificities of the monocarboxylate transporters of single rat heart cells.
We have used the intracellular pH-sensitive fluorescent dye 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein (BCECF) to characterize the substrate and inhibitor specificity of monocarboxylate transport into isolated rat heart cells. Further evidence was obtained for the presence of two lactate carriers present in heart cells (Wang et al., Biochem. J. 290: 249-258, 1993) both distinct from the recently cloned monocarboxylate transporter isoform 1 (MCT-1) found in many other cell types. Only one isoform was potently inhibited by alpha-cyano-4-hydroxycinnamate [CHC; inhibitor constant (Ki) 190 microM] and the stilbene disulfonates 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (Ki 79 microM) and 4,4'-dinitrostilbene-2,2'-disulfonate (Ki of cis- and trans-isomers 38 and 171 microM, respectively; neither isomer inhibits MCT-1). The second carrier had a Ki of approximately 3 mM for CHC and 0.5-2 mM for the stilbene disulfonates. Thus, unlike in many other tissues, in rat heart cells these inhibitors are not effective at blocking lactate transport totally unless used at very high concentrations. Both carriers were inhibited by 3-isobutyl-1-methylxanthine (Ki 340 microM) and neither by 5-nitro-2-(3-phenylpropylamino)benzoate (a potent inhibitor of MCT-1). The overall Michaelis constant (Km) and maximum reaction rate (Vmax) for transport of a variety of substituted monocarboxylates (C2-C5) were determined, although it was not possible to elucidate the kinetic parameters of the two isoforms. Of physiological interest, the ketone bodies D-beta-hydroxybutyrate and acetoacetate had K(m) values of 10 and 5.4 mM, respectively. Vmax values were similar to those of L-lactate and pyruvate and indicate that transport could limit rates of utilization of ketone bodies. No stereoselectivity for L-over D-isomers of 2-chloro or 2-hydroxy acids was observed.
Wang
X
X
Department of Biochemistry, School of Medical Sciences, University of Bristol, United Kingdom.
Levi
A J
AJ
Halestrap
A P
AP
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / Q000494:pharmacology; D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism*; D002469:Cell Separation; D002934:Cinnamates; D003373:Coumaric Acids / Q000494:pharmacology; D005452:Fluoresceins; D005456:Fluorescent Dyes; D007536:Isomerism; D019344:Lactic Acid / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics; D027501:Monocarboxylic Acid Transporters; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D013267:Stilbenes / Q000494:pharmacology; D013379:Substrate Specificity
D002352:Carrier Proteins; D002934:Cinnamates; D003373:Coumaric Acids; D005452:Fluoresceins; D005456:Fluorescent Dyes; D027501:Monocarboxylic Acid Transporters; D013267:Stilbenes; C018253:alpha-cyanocinnamate; D019344:Lactic Acid; C022306:4,4'-dinitro-2,2'-stilbenedisulfonic acid; C043829:2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein; D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; D015056:1-Methyl-3-isobutylxanthine